R&D | April 22, 2026
New brain study reveals why alcohol relapse remains a persistent challenge
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
Alkem’s semaglutide comes in a pre-filled disposable injection pen containing four doses for a month, priced at Rs. 1,800
Subscribe To Our Newsletter & Stay Updated
